Systemic complement depletion inhibits experimental cerebral vasospasm

Neurosurgery

Volumn 39, Issue 1, 1996, Pages 141-146

  German, John W ^a   Gross, Cordell E ^a,c   Giclas, Patricia ^b   Watral, William ^a   Bednar, Martin M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Complement; Rabbit; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

COBROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR ARTERY; BRAIN BLOOD VESSEL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEMOLYSIS; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; VASOSPASM;

ANIMALS; BASILAR ARTERY; COBRA VENOMS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; ISCHEMIC ATTACK, TRANSIENT; MALE; RABBITS; SUBARACHNOID HEMORRHAGE;

EID: 0030002139     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199607000-00028     Document Type: Article

References (33)

1. Alpers B, Forster F: The reparative processes in subarachnoid hemorrhage. J Neuropathol Exp Neurol 4:262-268, 1945.
2. Barrows LJ, Hunter FT, Banker BQ: The nature and clinical significance of pigments in the cerebrospinal fluid. Brain 78:59-80, 1955.
3. Chyatte D, Rusch N, Sundt T: Prevention of chronic experimental cerebral vasospasm with ibuprophen and high-dose methylprednisolone. J Neurosurg 59:925-932, 1983.
4. Frank M: Complement in the pathophysiology of human disease medical intelligence. N Engl J Med 316:1525-1530, 1987.
5. Fujii S, Hitomi Y: New synthetic inhibitors of C1s, C1 esterase, thrombin, plasmin, kallikrein, and trypsin. Biochim Biophys Acta 661:342-345, 1981.
6. Hammes E: Reaction of the meninges to blood. Arch Neurol Psychiatry 52:505-514, 1944.
7. Mansch G, Seitz M, Martinotti G, Betz M, Rauterberg E, Gemsa D: Macrophages release arachidonic acid, prostaglandin E2, and tromboxane in response to late complement components. J Immunol 133:2145-2150, 1984.
8. Jackowski A, Crockard A, Burnstock G, Russell RR, Kristek F: The time course of intracranial pathophysiological changes following experimental subarachnoid hemorrhage in the rat. J Cereb Blood Flow Metab 10:835-849, 1990.
9. Juvela S, Hillbom M, Kaste M: Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74:386-392, 1991.
10. Kabat EA, Mayer MM: Experimental Immunochemistry. Springfield, Charles C Thomas, 1961, ed 2, p 149.
11. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343, 1982.
12. Kassell NF, Sasaki T, Colohan AR, Nozar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985.
13. Kasuya H, Shimizu T: Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage. J Neurosurg 71:741-746, 1989.
14. Macdonald RL, Weir BKA: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
15. Mathiesen T, Andersson B, Loftenius A, Holst H: Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg 78:562-567, 1993.
16. Mathiesen T, Fuchs D, Wachter K, Holst H: Increased CSF neopterin levels in subarachnoid hemorrhage. J Neurosurg 73:69-71, 1990.
17. Mollnes TE, Fosse E: The complement system in trauma-related and ischemic tissue damage: A brief review. Shock 2:301-310, 1994.
18. Nakagomi T, Kassell N, Sasaki T, Lehman M, Fujiwara S: Etiology of the disruption in blood-arterial wall barrier following experimental subarachnoid hemorrhage. Surg Neurol 34:16-26, 1990.
19. Oda M, Ino Y, Nakamura K, Kuramoto S, Shmamura K, Iwaki M, Fujii S: Pharmacological studies on 6-amidino-2-naphthyl [4-(4, 5-dihydro-1H-imidazol-2-yl)amino] benzoate dimethane sulfonate (FUT-187): 1 - Inhibitory activities of various kinds of enzymes in vitro and anticomplement activity in vivo. Jpn J Pharmacol 52:23-34, 1990.
20. Ostergaard J, Kristensen B, Svehag S, Teisner B, Miletic T: Immune complexes and complement activation following rupture of intracranial saccular aneurysms. J Neurosurg 66:891-897, 1987.
21. Papadimitriou J, Ramm L, Drachenberg C, Trump B, Shin M: Quantitative analysis of adenine nucleorides during the prelytic phase of cell death mediated by C5b-9. J Immunol 147:212-217, 1991.
22. Pellettieri L, Carlsson CA, Lindholm L: Is the vasospasm following subarachnoidal hemorrhage an immunoreactive disease? Experientia 37:1170-1171, 1981.
23. Pellettieri LL, Nilsson B, Carlsson C, Nilsson U: Serum immunocomplexes in patients with subarachnoid hemorrhage. Neurosurgery 19:767-771, 1986.
24. Pickard JD, Murry GD, Shaw MDM, Teasdale GM, Foy PM, Humphrey PRD, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. Br Med J 298:636-642, 1989.
25. Deleted in proof.
26. Rossenwasser RH, Delgado TE, Buchheit WA, Freed MH: Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: Preliminary report. Neurosurgery 12:658-661, 1983.
27. Ryba M, Iwanska K, Walski M, Pastuszko M: Immunomodulators interfere with angiopathy but not vasospasm after subarachnoid haemorrhage in rabbits. Acta Neurochir (Wien) 108:81-84, 1991.
28. Sasaki T, Kassell N, Yamashita M, Fujiwara S, Zuccarello M: Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg 63:433-440,1985.
29. Weir B, Disney L, Grace M, Roberts P: Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 25:161-165, 1989.
30. Yanamoto H, Kikuchi H, Ishikawa J, Shimzu Y, Sato M, Tokuriki Y, Okarnoto S, Matsumoto M, Matsumoto K, Nakamura M: Intravenous FUT-175 inhibits complement activation in the cerebrospinal fluid and vasospasm-related delayed ischemic neurologic deficit following subarachnoid hemorrhage, in Findlay JM (ed): Cerebral Vasospasm. New York, Elsevier, 1993, pp 431-434.
31. Yanamoto H, Kikuchi H, Okamoto S: Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor. Surg Neurol 42:374-381, 1994.
32. Yanamoto H, Kikuchi H, Okamoto S, Nozaki K: Preventive effect of synthetic serine protease inhibitor, FUT-175, of cerebral vasospasm in rabbits. Neurosurgery 30:351-357, 1992.
33. Yokota M, Tani E, Maeda Y, Kokubu K: Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm. Stroke 18:512-518, 1987.